Description
The Alabama Department of Public Health is seeking a qualified laboratory to perform statewide cervical‑cancer screening services, including image‑guided Pap smear interpretation, Aptima HPV testing, primary HPV screening, genotyping, p16 biomarker analysis, and biopsy tissue processing for a variety of gynecologic specimens. The contract will be order‑driven, with the State issuing purchase orders as needed, and will run for an initial 12‑month base period with up to four additional 12‑month extensions.
• Required services: ThinPrep Pap reads (with Hologic imaging), Aptima high‑risk HPV, HPV‑only primary screening, HPV 16/18/45 genotyping, p16 immunohistochemistry, and histopathology of biopsy specimens from cervix, vulva, vagina, endometrium, ECC, ECB, LEEP, and polypectomy.
• Volume expectations: ~25,000 Pap tests, 20‑25 k HPV tests, ~2,500 biopsies, 300‑500 p16 stains annually (≈50,000 total specimens).
• Performance obligations: ≤7 business‑day turnaround for routine results, ≤48 hours for critical CIN 2‑3+/HSIL/cancer results; daily courier pickup; bidirectional EHR integration with ADPH’s CureMD system; monthly/quarterly statistical reporting; on‑site visits every two years.
• Mandatory qualifications: CLIA‑certified laboratory, board‑certified pathologist (cytopathology), ASCP‑registered cytotechnologists, $1 M general liability insurance, three references, and ability to accept electronic payments.
• Pricing: Unit‑price proposals required for each test category; freight must be FOB destination and included in bids; price escalation limited to CPI with written approval.